| Citation: |
LIU Ming, SHI Shuzhen, LU Cuncun, GAO Ya, CAI Yitong, TIAN Jinhui. Global Status and Trends of Tumor Hypoxia: A Scientometric Analysis[J]. Cancer Research on Prevention and Treatment, 2019, 46(12): 1078-1084. DOI: 10.3971/j.issn.1000-8578.2019.19.0711
|
This study aimed to explore the status quo, hot topics, and future prospects in the field of tumor hypoxia by scientometric analysis.
The literatures about tumor hypoxia were downloaded from the Web of Science Core Collection from inceptions to Dec.31st. 2018. We used CiteSpace 5.4.R1, VOSviewer 1.6.10 and Excel 2016 to analyze literature information, such as country, institution, author, keywords and references.
A total of 4399 papers about tumor hypoxia were identified, involving 20157 authors from 3604 institutions in 84 countries. Vaupel P, Harris AL and Dewhirst MW published the most literatures. United States, China and United Kingdom contributed the most publications. The three most contributed institutions are the University of Toronto, Stanford University and Oxford University. International Journal of Radiation Oncology Biology Physics (n=175, IF2017=5.554), Cancer Research (n=144, IF2017=9.13) and Radiotherapy Oncology (n=114, IF2017=4.942) are the most productive journals. The main hot topics in tumor hypoxia field are tumor hypoxic cells and cytokines, tumor hypoxia therapy, tumor hypoxia diagnosis, tumor hypoxia prognosis.
Developed countries in Europe and America are dominant in the field of tumor hypoxia research. The diagnosis and treatment of tumor hypoxic is still a difficult problem, especially how to overcome the drug resistance caused by tumor hypoxic.
| [1] |
Hammond EM, Asselin MC, Forster D, et al. The meaning, measurement and modification of hypoxia in the laboratory and the clinic[J]. Clin Oncol(R Coll Radiol), 2014, 26(5): 277-288. doi: 10.1016/j.clon.2014.02.002
|
| [2] |
Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects[J]. J Natl Cancer Inst, 2001, 93(4): 266-276. doi: 10.1093/jnci/93.4.266
|
| [3] |
Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome[J]. Cancer Metastasis Rev, 2007, 26(2): 225-239. doi: 10.1007/s10555-007-9055-1
|
| [4] |
Graham K, Unger E. Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment[J]. Int J Nanomedicine, 2018, 13: 6049-6058. doi: 10.2147/IJN.S140462
|
| [5] |
Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy[J]. Cancer Res, 1998, 58(7): 1408-1416. http://cn.bing.com/academic/profile?id=5289da21c9c2851320325ded4e4c9960&encoded=0&v=paper_preview&mkt=zh-cn
|
| [6] |
Vaupel P, Mayer A. Tumor Hypoxia: Causative Mechanisms, Microregional Heterogeneities, and the Role of Tissue-Based Hypoxia Markers[J]. Adv Exp Med Biol, 2016, 923: 77-86. http://cn.bing.com/academic/profile?id=dc3de245daadb086d5f0a527c03b07d1&encoded=0&v=paper_preview&mkt=zh-cn
|
| [7] |
Semenza GL. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression[J]. Crit Rev Biochem Mol Biol, 2000, 35(2): 71-103. doi: 10.1080/10409230091169186
|
| [8] |
Hockel M, Schlenger K, Aral B, et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix[J]. Cancer Res, 1996, 56(19): 4509-4515. http://cn.bing.com/academic/profile?id=af0f9af21e2737db1c5e78b802220510&encoded=0&v=paper_preview&mkt=zh-cn
|
| [9] |
Brizel D, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma[J]. Cancer Res, 1996, 56(5): 941-943. http://cn.bing.com/academic/profile?id=75963564c68ee6b7639656fa2e3eaced&encoded=0&v=paper_preview&mkt=zh-cn
|
| [10] |
Höckel M, Schlenger K, Höckel S, et al. Tumor hypoxia in pelvic recurrences of cervical cancer[J]. Int J Cancer, 1998, 79(4): 365-369. doi: 10.1002/(SICI)1097-0215(19980821)79:4<365::AID-IJC10>3.0.CO;2-4
|
| [11] |
Lou Y, Mcdonald PC, Oloumi A, et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase Ⅸ inhibitors[J]. Cancer Res, 2011, 71(9): 3364-3376. doi: 10.1158/0008-5472.CAN-10-4261
|
| [12] |
朱弈蒙, 张福利, 蔡润津, 等.国内医药卫生领域计算机辅助教学研究现状分析[J].中国医药导刊, 2019, 21(2): 115-120. doi: 10.3969/j.issn.1009-0959.2019.02.016
Zhu YM, Zhang FL, Cai RJ, et al. Study on the research status of computer assisted in medical field of China[J]. Zhongguo Yi Yao Dao Kan, 2019, 21(2): 115-120. doi: 10.3969/j.issn.1009-0959.2019.02.016
|
| [13] |
马文娟, 赵晔, 施树珍, 等.药物经济学研究评价指南的现状研究[J].中国药物评价, 2018, 35(1): 11-15. doi: 10.3969/j.issn.2095-3593.2018.01.004
Ma WJ, Zhao Y, Shi SZ, et al. Study on current situation of guidelines for assessing the pharmacoeconmics research[J]. Zhongguo Yao Wu Ping Jia, 2018, 35(1): 11-15. doi: 10.3969/j.issn.2095-3593.2018.01.004
|
| [14] |
赵婧, 张丽琴, 张冬泉, 等.基于中国生物医学文献数据库的VAP研究现状的可视化分析[J].中华危重病急救医学, 2018, 30(11): 1029-1035. doi: 10.3760/cma.j.issn.2095-4352.2018.11.004
Zhao J, Zhang LQ, Zhang DQ, et al. Visualization studies on research status of the ventilator-associated pneumonia based on SinoMed database[J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2018, 30(11): 1029-1035. doi: 10.3760/cma.j.issn.2095-4352.2018.11.004
|
| [15] |
Vaupel P, Mayer A. Hypoxia in tumors: pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implications[J]. Adv Exp Med Biol, 2014, 812: 19-24. http://cn.bing.com/academic/profile?id=fd34fc2cebb6aa67e8ec583850777c8d&encoded=0&v=paper_preview&mkt=zh-cn
|
| [16] |
Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology[J]. Semin Radiat Oncol, 2004, 14(3): 198-206. doi: 10.1016/j.semradonc.2004.04.008
|
| [17] |
Harris AL. Hypoxia-A key regulatory factor in tumour growth[J]. Nat Rev Cancer, 2002, 2(1): 38-47. doi: 10.1038/nrc704
|
| [18] |
Iggo R, Gatter K, Bartek J, et al. Increased expression of mutant forms of p53 oncogene in primary lung cancer[J]. Lancet, 1990, 335(8691): 675-679. doi: 10.1016/0140-6736(90)90801-B
|
| [19] |
Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size[J]. Cancer Res, 2000, 60(16): 4440-4445. http://cn.bing.com/academic/profile?id=00c4b2f1be9e10ba8a5057f83cb5abdc&encoded=0&v=paper_preview&mkt=zh-cn
|
| [20] |
Chen Q, Feng L, Liu J, et al. Intelligent Albumin-MnO2 Nanoparticles as pH-/H2O2-Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy[J]. Adv Mater, 2016, 28(33): 7129-7136. doi: 10.1002/adma.201601902
|
| [21] |
Wilson WR, Hay MP. Targeting hypoxia in cancer therapy[J]. Nat Rev Cancer, 2011, 11(6): 393-410. doi: 10.1038/nrc3064
|
| [22] |
Semenza GL. Targeting HIF-1 for cancer therapy[J]. Nat Rev Cancer, 2003, 3(10): 721-732. doi: 10.1038/nrc1187
|
| [23] |
Vaupel P, Multhoff G. Hypoxia-/HIF-1α-driven factors of the tumor microenvironment impeding antitumor immune responses and promoting malignant progression[J]. Adv Exp Med Biol, 2018, 1072: 171-175. http://cn.bing.com/academic/profile?id=510a17861553620d46702910abf0ae01&encoded=0&v=paper_preview&mkt=zh-cn
|
| [24] |
王宜宗, 顾科, 张军宁.肿瘤乏氧检测方法研究进展[J].肿瘤防治研究, 2007, 34(9): 724-726. doi: 10.3971/j.issn.1000-8578.3187
Wang YZ, Gu K, Zhang JN. Advances study in the detection of hypoxia in tumors[J]. Zhong Liu Fang Zhi Yan Jiu, 2007, 34(9): 724-726. doi: 10.3971/j.issn.1000-8578.3187
|
| [25] |
Stieb S, Eleftheriou A, Warnock G, et al. Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy[J]. Eur J Nucl Med Mol Imaging, 2018, 45(12): 2201-2217. doi: 10.1007/s00259-018-4116-y
|
| [26] |
Stern S, Guichard M. Efficacy of agents counteracting hypoxia in fractionated radiation regimes[J]. Radiother Oncol, 1996, 41(2): 143-149. doi: 10.1016-S0167-8140(96)01787-2/
|
| [27] |
Rojas A, Carl U, Reghebi K. Effect of normobaric oxygen on tumor radiosensitivity: fractionated studies[J]. Int J Radiat Oncol Biol Phys, 1990, 18(3): 547-553. doi: 10.1016/0360-3016(90)90059-S
|
| [28] |
Mazuryk O, Maciuszek M, Stochel G, et al. 2-Nitroimidazole-ruthenium polypyridyl complex as a new conjugate for cancer treatment and visualization[J]. J Inorg Biochem, 2014, 134: 83-91. doi: 10.1016/j.jinorgbio.2014.02.001
|
| [29] |
Hay MP, Hicks KO, Pruijn FB, et al. Pharmacokinetic/Pharmacodynamic Model-Guided Identification of Hypoxia-Selective 1, 2, 4-Benzotriazine 1, 4-Dioxides with Antitumor Activity: The Role of Extravascular Transport[J]. J Med Chem, 2007, 50(25): 6392-6404. doi: 10.1021/jm070670g
|
| [30] |
Shin SW, Jung W, Choi C, et al. Fucoidan-Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Co-Targeting Tumor Hypoxia and Angiogenesis[J]. Mar Drugs, 2018, 16(12). Pii: E510. doi: 10.3390/md16120510
|
| [31] |
Tanabe A, Tanikawa K, Tsunetomi M, et al. RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated[J]. Cancer Lett, 2016, 376(1): 34-42. http://www.ncbi.nlm.nih.gov/pubmed/26996300
|
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: